Average Co-Inventor Count = 3.39
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (32 from 1,535 patents)
2. Boehringer Ingelheim Pharma Kg (4 from 149 patents)
3. Boehringer Ingelheim Pharma Gmbh & Co Kg (3 from 194 patents)
4. Bi Pharma Kg. (1 from 1 patent)
40 patents:
1. 11919903 - Polymorphs
2. 11447474 - Solid forms of a GlyT1 inhibitor
3. 11084819 - Polymorphs
4. 10301313 - Polymorphs
5. 9815837 - Polymorphs
6. 9493462 - Polymorphs
7. 9309228 - Fumaric acid salt of 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one, its use as a medicament and the preparation thereof
8. 9266888 - Polymorphs
9. 9212183 - Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine
10. 8906931 - 9-[4-(3-chloro-2-fluoro-phenylamino-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5]undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
11. 8865729 - Salt forms of a xanthine compound
12. 8853225 - 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5] undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
13. 8686148 - Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
14. 8664222 - Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
15. 8637530 - 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals